Tapewire

NYSE · USD

ZTS

Zoetis Inc.

Export transactions ↓
Tapewire entity
679
SEC CIK
0001555280
Parsed reports
1,182

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 25, 2021 Filed Aug 26, 2021 21:08 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionStock Option · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,263

Underlying: Common Stock · 12,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 27,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
August 25, 2021 Filed Aug 26, 2021 21:08 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 2,506 $204.32 $512,025.92
Disclosure

SEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,924

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.02 to $204.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2021 Filed Aug 26, 2021 21:08 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 11,994 $203.39 $2,439,459.66
Disclosure

SEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,430

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.01 to $203.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2021 Filed Aug 26, 2021 21:08 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,000 $30.89 $370,680.00
Disclosure

SEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020.

Read SEC document
August 23, 2021 Filed Aug 24, 2021 16:51 UTC SaleCommon Stock 1,450 $207.10 $300,295.00
Disclosure

SEC source: 0001555280-21-000293 · wf-form4_162983828355544.xml · nonDerivative · entry 1

Reed Willie M · CIK 0001601695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,964

F1 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
August 23, 2021 Filed Aug 24, 2021 20:49 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 5,577 $207.33 $1,156,279.41
Disclosure

SEC source: 0001555280-21-000291 · wf-form4_162983818091613.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,874

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.00 to $207.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 23, 2021 Filed Aug 24, 2021 20:49 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 4,026 $206.71 $832,214.46
Disclosure

SEC source: 0001555280-21-000291 · wf-form4_162983818091613.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,451

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021.

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.00 to $206.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 31, 2021 Filed Aug 18, 2021 20:24 UTC
Nayak Abhay UExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 1,764.8277 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000289 · wf-form4_162931828363754.xml · derivative · entry 3

Nayak Abhay U · CIK 0001797754 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,266.9807

Underlying: Common Stock · 1,764.8277 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 1,764.8277 RSUs vested on July 31, 2021; 289.0936 RSUs will vest on February 12, 2022; 393.2935 RSUs will vest on February 11, 2023; and 584.5936 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 1,764.8277 RSUs vested on July 31, 2021; 289.0936 RSUs will vest on February 12, 2022; 393.2935 RSUs will vest on February 11, 2023; and 584.5936 RSUs will vest on February 10, 2024.

F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 1,764.8277 RSUs vested on July 31, 2021; 289.0936 RSUs will vest on February 12, 2022; 393.2935 RSUs will vest on February 11, 2023; and 584.5936 RSUs will vest on February 10, 2024.

Read SEC document
July 31, 2021 Filed Aug 18, 2021 20:24 UTC
Nayak Abhay UExecutive Vice President
Tax withholdingCommon Stock 605 $202.70 $122,633.50
Disclosure

SEC source: 0001555280-21-000289 · wf-form4_162931828363754.xml · nonDerivative · entry 2

Nayak Abhay U · CIK 0001797754 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159

Read SEC document
July 31, 2021 Filed Aug 18, 2021 20:24 UTC
Nayak Abhay UExecutive Vice President
Exercise / conversionCommon Stock 1,764 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000289 · wf-form4_162931828363754.xml · nonDerivative · entry 1

Nayak Abhay U · CIK 0001797754 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
July 22, 2021 Filed Jul 26, 2021 21:56 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 12,844 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · derivative · entry 4

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,860

Underlying: Common Stock · 12,844 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 12,844 options granted February 14, 2017 at an exercise price of $55.02 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
July 22, 2021 Filed Jul 26, 2021 21:56 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 5,640 $199.69 $1,126,251.60
Disclosure

SEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · nonDerivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,477

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.49 to $200.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 22, 2021 Filed Jul 26, 2021 21:56 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 16,810 $199.01 $3,345,358.10
Disclosure

SEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,117

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.49 to $199.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 22, 2021 Filed Jul 26, 2021 21:56 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 12,844 $55.02 $706,676.88
Disclosure

SEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 18:15 UTC
Pudloski Sherry NExecutive Vice President
GrantPhantom Stock Unit · Derivative 92.5905 $61.79 $5,721.17
Disclosure

SEC source: 0001555280-21-000276 · wf-form4_162681929200982.xml · derivative · entry 1

Pudloski Sherry N · CIK 0001806929 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149.4267

Underlying: Common Stock · 28.6517 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:14 UTC
PECK KRISTIN CDirector · Chief Executive Officer
GrantPhantom Stock Unit · Derivative 261.4323 $61.79 $16,153.90
Disclosure

SEC source: 0001555280-21-000275 · wf-form4_162681923897198.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,573.9527

Underlying: Common Stock · 80.8989 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:13 UTC
Nayak Abhay UExecutive Vice President
GrantPhantom Stock Unit · Derivative 87.1448 $61.79 $5,384.68
Disclosure

SEC source: 0001555280-21-000274 · wf-form4_162681919432793.xml · derivative · entry 1

Nayak Abhay U · CIK 0001797754 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 543.7424

Underlying: Common Stock · 26.9665 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:12 UTC
Mamilli WafaaExecutive Vice President
GrantPhantom Stock Unit · Derivative 130.7161 $61.79 $8,076.95
Disclosure

SEC source: 0001555280-21-000273 · wf-form4_162681913840517.xml · derivative · entry 1

Mamilli Wafaa · CIK 0001800960 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,568.7733

Underlying: Common Stock · 40.4495 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:11 UTC
Lagano RoxanneExecutive Vice President
GrantPhantom Stock Unit · Derivative 122.0021 $61.79 $7,538.51
Disclosure

SEC source: 0001555280-21-000272 · wf-form4_162681907396787.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,906.0239

Underlying: Common Stock · 37.753 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:08 UTC
Knupp Catherine A.Executive Vice President
GrantPhantom Stock Unit · Derivative 154.6809 $61.79 $9,557.73
Disclosure

SEC source: 0001555280-21-000270 · wf-form4_162681890206823.xml · derivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,209.662

Underlying: Common Stock · 47.8652 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:07 UTC
David GlennExecutive Vice President
GrantPhantom Stock Unit · Derivative 157.9492 $61.79 $9,759.68
Disclosure

SEC source: 0001555280-21-000269 · wf-form4_162681885868056.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,038.5376

Underlying: Common Stock · 48.8766 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:07 UTC
Chen Heidi C.Executive Vice President
GrantPhantom Stock Unit · Derivative 133.9845 $61.79 $8,278.90
Disclosure

SEC source: 0001555280-21-000268 · wf-form4_162681881301359.xml · derivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,832.4255

Underlying: Common Stock · 41.4608 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 22:06 UTC
Bettington Timothy JExecutive Vice President
GrantPhantom Stock Unit · Derivative 122.0021 $61.79 $7,538.51
Disclosure

SEC source: 0001555280-21-000267 · wf-form4_162681875563686.xml · derivative · entry 1

Bettington Timothy J · CIK 0001797894 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,573.4707

Underlying: Common Stock · 37.753 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:22 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionStock Option · Derivative 3,285 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · derivative · entry 3

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,896

Underlying: Common Stock · 3,285 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 3,287 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:22 UTC
Trawicki RomanExecutive Vice President
SaleCommon Stock 4,492 $187.00 $840,004.00
Disclosure

SEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · nonDerivative · entry 2

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,210

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:22 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionCommon Stock 3,285 $73.24 $240,593.40
Disclosure

SEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · nonDerivative · entry 1

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,702

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:28 UTC
Joseph WettenyChief Financial Officer
GrantRestricted Stock Unit · Derivative 7,512 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 2

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,366

Underlying: Common Stock · 7,512 shares

Expires not disclosed

F5 · security: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F6 · derivative.exercise_date: Each vested restricted stock unit will be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:28 UTC
Joseph WettenyChief Financial Officer
GrantRestricted Stock Unit · Derivative 19,854 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 1

Joseph Wetteny · CIK 0001285781 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,854

Underlying: Common Stock · 19,854 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each restricted stock unit will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F1 · balance_after: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Read SEC document
June 24, 2021 Filed Jun 25, 2021 20:34 UTC GrantPhantom Stock Unit · Derivative 168.5727 $185.38 $31,250.01
Disclosure

SEC source: 0001555280-21-000253 · wf-form4_162465324708877.xml · derivative · entry 1

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,472.5318

Underlying: Common Stock · 168.5727 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

Read SEC document
June 04, 2021 Filed Jun 23, 2021 20:25 UTC
Chen Heidi C.Executive Vice President
GiftCommon Stock 550 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000248 · wf-form4_162447991484551.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,095

Read SEC document
May 25, 2021 Filed May 26, 2021 21:16 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionStock Option · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,263

Underlying: Common Stock · 12,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 39,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
May 25, 2021 Filed May 26, 2021 21:16 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 4,900 $175.94 $862,106.00
Disclosure

SEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,424

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.70 to $176.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 25, 2021 Filed May 26, 2021 21:16 UTC
PECK KRISTIN CDirector · Chief Executive Officer
SaleCommon Stock 9,600 $175.20 $1,681,920.00
Disclosure

SEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,324

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.69 to $175.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 25, 2021 Filed May 26, 2021 21:16 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,000 $30.89 $370,680.00
Disclosure

SEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020.

Read SEC document
May 20, 2021 Filed May 21, 2021 20:39 UTC
Knupp Catherine A.Executive Vice President
SaleCommon Stock 8,283 $175.16 $1,450,850.28
Disclosure

SEC source: 0001555280-21-000234 · wf-form4_162162956453502.xml · nonDerivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,642

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $174.95 to $175.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
May 20, 2021 Filed May 24, 2021 17:20 UTC Exercise / conversionRestricted Stock Unit · Derivative 5,702.937 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · derivative · entry 4

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,702.937 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F8 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F9 · derivative.expiration_date: Not applicable.

Read SEC document
May 20, 2021 Filed May 24, 2021 17:20 UTC Exercise / conversionDeferred Stock Unit · Derivative 10,469.5783 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · derivative · entry 3

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,469.5783 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents deferred stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs were fully vested on the date of the grant and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

F4 · derivative.exercise_price: Each DSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F5 · derivative.exercise_date: Each DSU will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director of Zoetis Inc.

F5 · derivative.expiration_date: Each DSU will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director of Zoetis Inc.

Read SEC document
May 20, 2021 Filed May 24, 2021 17:20 UTC Exercise / conversionCommon Stock 5,702 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · nonDerivative · entry 2

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F2 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
May 20, 2021 Filed May 24, 2021 17:20 UTC Exercise / conversionCommon Stock 10,468 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · nonDerivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,372

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of deferred stock units (DSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each DSU represents a right to receive one share of Zoetis Inc. common stock upon settlement of the DSU.

F1 · price: Acquisition of common stock upon vesting and settlement of deferred stock units (DSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each DSU represents a right to receive one share of Zoetis Inc. common stock upon settlement of the DSU.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:22 UTC Disposition to issuerRestricted Stock Unit · Derivative 1,302.2257 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · derivative · entry 3

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,783.8375

Underlying: Common Stock · 1,302.2257 shares

Expires not disclosed

F2 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F4 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F5 · derivative.expiration_date: Not applicable.

F7 · balance_after: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:22 UTC Exercise / conversionRestricted Stock Unit · Derivative 130.8769 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · derivative · entry 2

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,086.0632

Underlying: Common Stock · 130.8769 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F4 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F5 · derivative.expiration_date: Not applicable.

F6 · balance_after: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022; and 1,302.2257 RSUs will vest on February 10, 2024.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:22 UTC Exercise / conversionCommon Stock 130 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · nonDerivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,129

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
May 19, 2021 Filed May 21, 2021 20:41 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 4,638 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · derivative · entry 5

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,704

Underlying: Common Stock · 4,638 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F8 · derivative.exercise_price: 4,638 options granted February 14, 2017 at an exercise price of $55.02 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F9 · balance_after: 12,844 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
May 19, 2021 Filed May 21, 2021 20:41 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 1,362 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · derivative · entry 4

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,342

Underlying: Common Stock · 1,362 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 1,362 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
May 19, 2021 Filed May 21, 2021 20:41 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 6,000 $169.05 $1,014,300.00
Disclosure

SEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · nonDerivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,083

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
May 19, 2021 Filed May 21, 2021 20:41 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 4,638 $55.02 $255,182.76
Disclosure

SEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,083

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed May 21, 2021 20:41 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 1,362 $41.83 $56,972.46
Disclosure

SEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:21 UTC
Kelly Robert EdwardExecutive Vice President
Exercise / conversionStock Option · Derivative 728 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · derivative · entry 5

Kelly Robert Edward · CIK 0001798683 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,136

Underlying: Common Stock · 728 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F8 · derivative.exercise_price: 728 options granted March 4, 2014 at an exercise price of $30.89 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F9 · balance_after: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 5,824 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:21 UTC
Kelly Robert EdwardExecutive Vice President
Exercise / conversionStock Option · Derivative 820 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · derivative · entry 4

Kelly Robert Edward · CIK 0001798683 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,864

Underlying: Common Stock · 820 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 820 options granted January 31, 2013 at an exercise price of $26.00 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 6,552 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
May 03, 2021 Filed May 4, 2021 20:21 UTC
Kelly Robert EdwardExecutive Vice President
SaleCommon Stock 2,053 $174.70 $358,659.10
Disclosure

SEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · nonDerivative · entry 3

Kelly Robert Edward · CIK 0001798683 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,300

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.